Mr. Doron Birger is a high-tech industry executive with a background in bringing groundbreaking products to market.  He has more than 30 years of experience in the Israeli high-tech sector as a chief executive officer, board chairman, director, and advisor to several private and publicly traded firms, with an emphasis in the life science industry.  Key positions previously held by Mr. Birger include: president and Chief Executive Officer of Elron (Nasdaq, TASE: ELRNF) (2002-2009), Chairman of the Board at Given Imaging (2002-2007), and a director until it was sold to Covidien in 2014. Mr. Birger was also the Chief Financial Officer at several companies from various sectors (1978-2001), including the CFO of Elron (1994-2001). Mr Birger currently chairs several technology companies, including Sight Diagnostic, Ultrasight, Nurami, Matricelf (TASE: MTLF), and Intelicanna (TASE: INTL). He is also a director in a variety of medical device and advanced technology companies, including IceCure (TASE: ICCM), Citrine Global (OTCQB: CTGL), Kadimastem (TASE: KDST), HeraMED (ASX: HMD) Vibrant, and Netive Haor. Mr. Birger earned his bachelor’s degree and Master of Economics from the Hebrew University, Jerusalem.